84 related articles for article (PubMed ID: 26902354)
1. The Mechanism of Adaptation of Breast Cancer Cells to Hypoxia: Role of AMPK/mTOR Signaling Pathway.
Sorokin DV; Scherbakov AM; Yakushina IA; Semina SE; Gudkova MV; Krasil'nikov MA
Bull Exp Biol Med; 2016 Feb; 160(4):555-9. PubMed ID: 26902354
[TBL] [Abstract][Full Text] [Related]
2. Interactions between HIF-1α and AMPK in the regulation of cellular hypoxia adaptation in chronic kidney disease.
Li H; Satriano J; Thomas JL; Miyamoto S; Sharma K; Pastor-Soler NM; Hallows KR; Singh P
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F414-28. PubMed ID: 26136559
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK/REDD1 signaling axis in head and neck squamous cell carcinoma.
Schneider A; Younis RH; Gutkind JS
Neoplasia; 2008 Nov; 10(11):1295-302. PubMed ID: 18953439
[TBL] [Abstract][Full Text] [Related]
5. Vitronectin-αvβ3 integrin engagement directs hypoxia-resistant mTOR activity and sustained protein synthesis linked to invasion by breast cancer cells.
Pola C; Formenti SC; Schneider RJ
Cancer Res; 2013 Jul; 73(14):4571-8. PubMed ID: 23722547
[TBL] [Abstract][Full Text] [Related]
6. St. John's Wort Regulates Proliferation and Apoptosis in MCF-7 Human Breast Cancer Cells by Inhibiting AMPK/mTOR and Activating the Mitochondrial Pathway.
You MK; Kim HJ; Kook JH; Kim HA
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29570671
[TBL] [Abstract][Full Text] [Related]
7. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
8. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
Scherbakov AM; Sorokin DV; Tatarskiy VV; Prokhorov NS; Semina SE; Berstein LM; Krasil'nikov MA
IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
[TBL] [Abstract][Full Text] [Related]
9. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
[TBL] [Abstract][Full Text] [Related]
10. Polyphenolics from mango (Mangifera indica L.) suppress breast cancer ductal carcinoma in situ proliferation through activation of AMPK pathway and suppression of mTOR in athymic nude mice.
Nemec MJ; Kim H; Marciante AB; Barnes RC; Hendrick ED; Bisson WH; Talcott ST; Mertens-Talcott SU
J Nutr Biochem; 2017 Mar; 41():12-19. PubMed ID: 27951515
[TBL] [Abstract][Full Text] [Related]
11. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
12. Activation of autophagy through calcium-dependent AMPK/mTOR and PKCθ pathway causes activation of rat hepatic stellate cells under hypoxic stress.
Jin Y; Bai Y; Ni H; Qiang L; Ye L; Shan Y; Zhou M
FEBS Lett; 2016 Mar; 590(5):672-82. PubMed ID: 26848942
[TBL] [Abstract][Full Text] [Related]
13. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
[TBL] [Abstract][Full Text] [Related]
14. Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.
Chang WL; Hsu LC; Leu WJ; Chen CS; Guh JH
Oncotarget; 2015 Nov; 6(37):39806-20. PubMed ID: 26447757
[TBL] [Abstract][Full Text] [Related]
15. Silencing Nrf2 impairs glioma cell proliferation via AMPK-activated mTOR inhibition.
Jia Y; Wang H; Wang Q; Ding H; Wu H; Pan H
Biochem Biophys Res Commun; 2016 Jan; 469(3):665-71. PubMed ID: 26692480
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
17. AMPK-mTOR Signaling and Cellular Adaptations in Hypoxia.
Chun Y; Kim J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575924
[TBL] [Abstract][Full Text] [Related]
18. Activation of phosphatidylinositol 3-kinase, Akt, and mammalian target of rapamycin is necessary for hypoxia-induced pulmonary artery adventitial fibroblast proliferation.
Gerasimovskaya EV; Tucker DA; Stenmark KR
J Appl Physiol (1985); 2005 Feb; 98(2):722-31. PubMed ID: 15501927
[TBL] [Abstract][Full Text] [Related]
19. AMP-activated protein kinase activity is required for vanadate-induced hypoxia-inducible factor 1alpha expression in DU145 cells.
Hwang JT; Lee M; Jung SN; Lee HJ; Kang I; Kim SS; Ha J
Carcinogenesis; 2004 Dec; 25(12):2497-507. PubMed ID: 15297373
[TBL] [Abstract][Full Text] [Related]
20. Alteration of REDD1-mediated mammalian target of rapamycin pathway and hypoxia-inducible factor-1α regulation in human breast cancer.
Koo JS; Jung W
Pathobiology; 2010; 77(6):289-300. PubMed ID: 21266827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
